These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2543648)

  • 21. Cellular immunity to murine sarcoma virus-induced tumors as measured by macrophage migration inhibition assays.
    Landolfo S; Herberman RB; Holden HT
    J Natl Cancer Inst; 1977 Dec; 59(6):1675-83. PubMed ID: 200758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PAb1614, a monoclonal antibody reactive with the tumor antigens of SV40, JC, BK, and polyoma virus, and other JC virus tumor antigen cross-reactive antibodies of the PAb1601-1636 panel.
    Hess R; Oberbeck J; Grussenmeyer T; Schoeffel-Keller A; Haessler C; Braun DG; Brandner G
    Intervirology; 1994; 37(1):47-52. PubMed ID: 7523331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The production of migration inhibition factor by B and T cells of the guinea pig.
    Yoshida T; Sonozaki H; Cohen S
    J Exp Med; 1973 Oct; 138(4):784-97. PubMed ID: 4582841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of H-2Kb-, Db- and Dd-binding peptides derived from amino acid sequences of polyoma virus T antigens.
    Reinholdsson-Ljunggren G; Franksson L; Dalianis T; Ljunggren HG
    Int J Cancer; 1993 Jul; 54(6):992-5. PubMed ID: 8335406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Induction of T-cell producers of the macrophage migration inhibitory factor by the products of the K-, I- and D-regions of the H-2 complex in mice].
    Kharkevich DD; Suslov AP
    Biull Eksp Biol Med; 1985 Apr; 99(4):484-6. PubMed ID: 3886043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Induction of macrophage migration inhibition factor-producing cells in vitro].
    Krylov OR; Avdeeva ZhI; Podoplelov II; Medunitsyn NV
    Biull Eksp Biol Med; 1986 Jun; 101(6):715-7. PubMed ID: 3524700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-10 inhibits the synthesis of migration inhibitory factor and migration inhibitory factor-mediated macrophage activation.
    Wu J; Cunha FQ; Liew FY; Weiser WY
    J Immunol; 1993 Oct; 151(8):4325-32. PubMed ID: 7691945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the polyoma tumor-specific transplantation antigen (TSTA): selection and characterization of TSTA-negative segregants from somatic hybrids.
    Ramqvist T; Reinholdsson G; Szigeti R; Klein G; Dalianis T
    Int J Cancer; 1987 Jul; 40(1):74-80. PubMed ID: 3036722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyoma virus-induced tumor-specific transplantation antigen (TSTA) is a mouse and rat cross-species-reacting antigen.
    Ramqvist T; Dalianis T
    Eur J Cancer Clin Oncol; 1984 Dec; 20(12):1557-60. PubMed ID: 6094200
    [No Abstract]   [Full Text] [Related]  

  • 30. The mutagenic and immortalizing potential of polyoma virus large T antigen.
    Strauss M; Lübbe L; Kiessling U; Platzer M; Griffin BE
    Curr Top Microbiol Immunol; 1989; 144():129-134. PubMed ID: 2551578
    [No Abstract]   [Full Text] [Related]  

  • 31. [Nature of the cells regulating the production of a migration inhibition factor in C57BL/6 strain mice with low response to Candida albicans antigen].
    Vorob'ev KV; Koval'chuk LV; Gankovskaia LV
    Biull Eksp Biol Med; 1984 Nov; 98(11):601-2. PubMed ID: 6239664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro generation of therapeutic noncytolytic T-cells by soluble polyoma TAA and Il-2.
    Ochalek T; von Kleist S
    Anticancer Res; 1993; 13(4):1171-7. PubMed ID: 8394674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell transformation by the middle T-antigen of polyoma virus.
    Ichaso N; Dilworth SM
    Oncogene; 2001 Nov; 20(54):7908-16. PubMed ID: 11753673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Desensitization. V: Suppression of MIF production by lymphokine-activated macrophages.
    Suko M; Yoshida T; Cohen S
    Cell Immunol; 1985 Nov; 96(1):49-60. PubMed ID: 2941156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies specific for the polyoma virus middle-size tumor antigen.
    Walter G; Hutchinson MA; Hunter T; Eckhart W
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):4882-6. PubMed ID: 6272281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage migration inhibition as a correlate of cell-mediated immunity to herpes simplex virus type 2 in mice.
    Mogensen SC
    Immunobiology; 1982; 162(1):28-38. PubMed ID: 6286467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Manipulation of macrophage migration inhibition/stimulation responses by adjuvants and interleukins.
    MacSween JM; Rajaraman R; Rajaraman S
    Int Arch Allergy Appl Immunol; 1990; 92(4):343-8. PubMed ID: 2083970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T antigens' role in polyomavirus transformation: c-myc but not c-fos or c-jun expression is a target for middle T.
    Rameh LE; Armelin MC
    Oncogene; 1991 Jun; 6(6):1049-56. PubMed ID: 1648700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased macrophage migration inhibition factor production in hamsters sensitized by amoebic antigen and glucan.
    Haq A; Sharma A; Ahmad S
    Parasite Immunol; 1984 Jul; 6(4):391-6. PubMed ID: 6089076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulation of mouse migration inhibitory factor (MIF) production form MSV-immune lymphocytes by soluble tumor-associated antigen: requirement for histocompatible macrophages.
    Landolfo S; Herberman RB; Holden HT
    J Immunol; 1977 Apr; 118(4):1244-8. PubMed ID: 191532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.